Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Cai, Shao hang ^a   Lv, Fang fang ^b   Zhang, Yong hong ^c   Jiang, Ye gui ^d   Peng, Jie ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cobas TaqMan; Daan Test; HBeAg; HBV DNA quantification; Hepatitis B virus; Serum; Viral load

Indexed keywords

ADEFOVIR; ADENINE; ANTIVIRUS AGENT; ENTECAVIR; GUANINE; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE; VIRUS DNA;

ADOLESCENT; ADULT; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PROCEDURES; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADENINE; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; GUANINE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; YOUNG ADULT;

EID: 84893765289     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-85     Document Type: Article

References (23)

1. Liaw YF. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 2009, 51:403-410. 10.1016/j.jhep.2009.04.003, 19467727.
2. Chen P, Yu C, Wu W, Wang J, Ruan B, Ren J, Yang S, Xu K, Yu L, Li L. Serological profile among HBsAg-positive infections in Southeast China: a community-based study. Hepat Mon 2013, 13:e7604. 3589882, 23483608.
3. Lin YY, Huang JF, Liu SF, Yu ML, Tsai CH, Yang JF, Lin IL, Dai CY, Lin ZY, Chen SC, Chang WY, Chuang WL. Performance characteristics of two real-time PCR assays for quantification of hepatitis B virus DNA. Scand J Infect Dis 2009, 41:614-618. 10.1080/00365540902875073, 19360504.
4. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007, 45:507-539. 10.1002/hep.21513, 17256718.
5. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002, 347:168-174. 10.1056/NEJMoa013215, 12124405.
6. European Association for the Study of the Liver EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012, 57:167-185. European Association for the Study of the Liver.
7. Karabay O, Tuna N, Esen S. Comparative efficacy of pegylated interferons alpha-2a and 2b in the treatment of HBeAg-negative chronic hepatitis B infection. Eur J Gastroenterol Hepatol 2012, 24:1296-1301.
8. Wang Y, Thongsawat S, Gane EJ, Liaw YF, Jia J, Hou J, Chan HL, Papatheodoridis G, Wan M, Niu J, Bao W, Trylesinski A, Naoumov NV. Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B. J Viral Hepat 2013, 20:e37-e46. 10.1111/jvh.12025, 3618368, 23490388.
9. Dogan UB, Golge N, Akin MS. The comparison of the efficacy of pegylated interferon alpha-2a and alpha-2b in chronic hepatitis B patients. Eur J Gastroenterol Hepatol 2013, .
10. Yang JX, Liu BM, Li XG, Yan CH, Xu J, Sun XW, Wang YH, Jiao XJ, Yan L, Dong JP, Hou CS, Abuduheilili X, Li T, Zhuang H. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients. Antivir Ther 2010, 15:1171-1178. 10.3851/IMP1677, 21149924.
11. Cai T, Lou G, Yang J, Xu D, Meng Z. Development and evaluation of real-time loop-mediated isothermal amplification for hepatitis B virus DNA quantification: a new tool for HBV management. J Clin Virol 2008, 41:270-276. 10.1016/j.jcv.2007.11.025, 18296109.
12. Dai CY, Yu ML, Chen SC, Lin ZY, Hsieh MY, Wang LY, Tsai JF, Chuang WL, Chang WY. Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan. J Clin Pathol 2004, 57:141-145. 10.1136/jcp.2003.10835, 1770196, 14747437.
13. Yuan HJ, Yuen MF, Wong DK, Sum SS, Lai CL. Clinical evaluation of the digene hybrid capture II test and the COBAS AMPLICOR monitor test for determination of hepatitis B virus DNA levels. J Clin Microbiol 2004, 42:3513-3517. 10.1128/JCM.42.8.3513-3517.2004, 497578, 15297491.
14. Yim HJ, Byun KS, Chang YJ, Suh YS, Yeon JE, Lee CH, Kwon JA, Yoo W, Kim SO, Hong SP. Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea. Dig Dis Sci 2007, 52:2403-2409. 10.1007/s10620-006-9140-2, 17429737.
15. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M, Kohara M. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 1999, 37:2899-2903. 85408, 10449472.
16. Shi M, Zhang Y, Zhu YH, Zhang J, Xu WJ. Comparison of real-time polymerase chain reaction with the COBAS Amplicor test for quantitation of hepatitis B virus DNA in serum samples. World J Gastroenterol 2008, 14:479-483. 10.3748/wjg.14.479, 2679140, 18200674.
17. Welzel TM, Miley WJ, Parks TL, Goedert JJ, Whitby D, Ortiz-Conde BA. Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G. J Clin Microbiol 2006, 44:3325-3333. 10.1128/JCM.00024-06, 1594718, 16954268.
18. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008, 2:263-283. 10.1007/s12072-008-9080-3, 2716890, 19669255.
19. Mangia A, Antonucci F, Brunetto M, Capobianchi M, Fagiuoli S, Guido M, Farci P, Lampertico P, Marzano A, Niro G, Pisani G, Prati D, Puoti M, Raimondo G, Santantonio T, Smedile A, Lauria F, Italian Association for the Study of the Liver (AISF) The use of molecular assays in the management of viral hepatitis. Dig Liver Dis 2008, 40:395-404. 10.1016/j.dld.2007.12.016, 18321798, Italian Association for the Study of the Liver (AISF).
20. Lampertico P, Vigano M, Manenti E, Iavarone M, Lunghi G, Colombo M. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Hepatology 2005, 42:1414-1419. 10.1002/hep.20939, 16317671.
21. Papatheodoridis GV, Dimou E, Dimakopoulos K, Manolakopoulos S, Rapti I, Kitis G, Tzourmakliotis D, Manesis E, Hadziyannis SJ. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine. Hepatology 2005, 42:121-129.
22. Sung JJ, Lai JY, Zeuzem S, Chow WC, Heathcote EJ, Perrillo RP, Brosgart CL, Woessner MA, Scott SA, Gray DF, Gardner SD. Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B. J Hepatol 2008, 48:728-735. 10.1016/j.jhep.2007.12.026, 18329126.
23. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662. 10.1002/hep.23190, 19714720.